| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dukiprubart | SGC-001; ZYB-0069 | Phase 2 Clinical | Beijing Sungen Biomedical Technology Co Ltd | Anterior Wall Myocardial Infarction; Myocardial Infarction; ST Elevation Myocardial Infarction | Details |
| Tasquinimod | ABR-215050; TASQ; ABR-5050 | Phase 2 Clinical | Active Biotech Ab | Carcinoma, Renal Cell; Hormone-Resistant Prostate Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Thrombocythemia, Essential | Details |